Remodulin
Ended Awarded Last action
- Contract number
- 36C25019F0609
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $180,703
Award facts
- Contract value 100% obligated
- $180,703.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$642 | |
| Funding Only Action | -$13,686 | |
| Other Administrative Action | $0 | |
| Original award | $195,031 |
About this award
This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to United Therapeutics Corp, a biotechnology company that manufactures pharmaceutical products. The contract is a Blanket Purchase Agreement (BPA) Call against United Therapeutics' pre-competed Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs, with a potential value of $180,703.25. The contract provides the VA with United Therapeutics' specialty drugs, including Remodulin, Tyvaso, Orenitram, and Unituxin, which are used to treat pulmonary arterial hypertension and hematologic cancers in veterans. The contract had no set-aside designation and was awarded on a firm fixed price basis, with United Therapeutics delivering the pharmaceutical products directly to VA medical facilities and clinics across over 20 states. This award is part of United Therapeutics' larger $50 million BPA and $198 million task order with the VA, which streamline the agency's distribution of the company's targeted therapies to veterans nationwide.
Quick answers
Who was awarded contract 36C25019F0609?
36C25019F0609 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 10 (Veterans Health Administration) on January 9, 2019.
How much is contract 36C25019F0609 worth?
The government has obligated $180,703 on 36C25019F0609.
Is contract 36C25019F0609 an order under another contract?
Yes. 36C25019F0609 is a BPA call under V797D40275-VA797P15A0007, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25019F0609 competed?
The extent of competition for 36C25019F0609 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award